Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function

• Κύριοι συγγραφείς: Christopher M Blanchette (Συγγραφέας), Anthony P Nunes (Συγγραφέας), Nancy D Lin (Συγγραφέας), Kathleen M Mortimer (Συγγραφέας), Joshua Noone (Συγγραφέας), Krishna Tangirala (Συγγραφέας), Stephen Johnston (Συγγραφέας), Benjamin Gutierrez (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BioExcel Publishing Ltd, 2015-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Risk evaluation and mitigation strategies (REMS), as mandated by the US Food and Drug Administration (FDA) for medications with the potential for harm, are increasingly incorporating rigid protocols for patient evaluation, but little is known about compliance with these programs. Despite...